Access to Rare Indications Act of 2020

Summary

Access to Rare Indications Act of 2020 This bill prohibits coverage exclusions or limitations under the Medicare prescription drug benefit, Medicaid, or private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals and that are supported by the National Institutes of Health Rare Diseases Clinical Research Network).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 30 September 2020

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 30 September 2020

   Introduced

   Introduced in House

   Source: IntroReferral

3. 30 September 2020

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 30 September 2020 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 30 September 2020

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 30 September 2020

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 30 September 2020

  Open at official source

Sponsors

• Rep. Thompson, Mike [D-CA-4] · D · Sponsor
• Rep. Kelly, Mike [R-PA-16] · R · Sponsor
• · hswm00 · Standing
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.